FDA Inspection 1086418 - Boehringer Ingelheim Pharma Gmbh & Co Kg - April 05, 2019

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on April 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharma Gmbh & Co Kg
Inspection Date: April 5, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61

Violation Codes2

21 CFR 211.160(a)21 CFR 211.192

Full citation text and observation details available on the Dashboard.